Moderna Pediatric COVID-19 Vaccine
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- 75D30125D20470
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75D30125D20470 Federal IDV award
- Awardee
- Moderna US, Inc.
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Atlanta, Georgia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The CDC Office of Acquisition Services has issued a sole source justification notice for the procurement of Moderna's pediatric COVID-19 vaccine (SPIKEVAX) for children aged 6 months to 11 years. The agency is modifying an existing indefinite delivery, indefinite quantity (IDIQ) contract to increase available doses from Moderna following the anticipated removal of Pfizer's competing EUA-designated pediatric COVID vaccine from the market. The sole source justification is based on the fact that once the public health emergency ends and EUA products are withdrawn, Moderna's licensed vaccine will be the only available product in the United States for children aged 6 months to 4 years. The vaccines will support the Vaccine for Children (VFC) program and Section 317(j) immunization programs distributed to state health departments, large city programs, and U.S. territories through NCIRD's electronic vaccine ordering system. While the notice indicates this is a follow-on modification to existing contracts initially established for children 0-18 years of age, specific award values and quantities are not disclosed in the available documentation.
Notice text
CDC Office of Acquisition Services awarded multiple indefinite delivery, indefinite quantity (IDIQ) contracts for the National Center for Immunization and Respiratory Diseases (NCIRD) for the purchase of standard commercial pediatric COVID vaccines, manufactured under a current establishment and product license issued by the U.S. Food and Drug Administration (FDA). The vaccines awarded under these contracts will be purchased for NCIRD’s immunization awardees (the fifty state health departments, several large city program and current and former U.S. Territories) to support immunization programs as provided under Section 317(j) of the Public Health Service Act and Vaccine for Children (VFC) program, as established pursuant to Section 13631of the Omnibus Budget Reconciliation Act of 1993. Orders for the vaccines on these contracts are ordered through the NCIRD electronic vaccine ordering system. The initial contracts were established to support the public sector ACIP recommended COVID vaccinations for children 0 - 18 years of age. The Moderna contract will be modified to support additional purchase of doses for the licensed pediatric COVID vaccine (SPIKEVAX) with an age indication of 6 months to 11 years. With no declared public health emergency and the existence of licensed products for all applicable age groups, a decision is expected to remove COVID vaccines with Emergency Use Authorization (EUA) designations from the market. This means the Pfizer pediatric COVID vaccine with an EUA for ages 6 months to 4 years will no longer be available to support the VFC program. This will leave Moderna's COVID vaccine with the age indication of 6 months to 11 years as the only licensed product in the US for children 6 months to 4 years. As such, it is in the best interest of the government to increase Moderna's available doses to mitigate the removal of the Pfizer product. CDC intends on awarding a sole source follow on action to Moderna to allow for the additional purchase of the licensed pediatric COVID vaccine. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.
Awarded contract 75D30125D20470 to unknown vendor for unknown amount on 2025-06-01.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity